Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PLEKHG2 is a large multidomain signaling protein (about 1300 amino acids, 130 kDa) that functions as a guanine nucleotide exchange factor (GEF) mainly for the Rho family GTPases Rac1 and Cdc42, with recognized roles in regulating actin polymerization and cell morphology. It is activated by direct interaction with the beta and gamma subunits of heterotrimeric G proteins downstream of G protein-coupled receptors, enabling key cellular processes such as chemotaxis and cell motility. PLEKHG2 is implicated in the development and maintenance of neuronal structures, including axons, dendrites, and synaptic spines, with mutations (esp. Arg204Trp) causing severe neurodevelopmental disorders such as microcephaly, intellectual disability, and dystonia. It also has oncogenic potential, particularly in leukemias. Protein interactions include Gβγ, β-actin, FHL1, and Gαs, and it is subject to regulation by phosphorylation via signals such as SRC and EGFR. The precise physiological role and therapeutic targeting strategies remain under investigation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pleckstrin homology domain-containing family G member 2 (PLEKHG2).